LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 20 Aug 2003 10:40:39 +0200
Content-Type:
text/plain
Parts/Attachments:
text/plain (49 lines)
http://www.blackwell-synergy.com/links/doi/10.1046/j.1440-1754.2003.00178.x

      Journal of Paediatrics and Child Health
      Volume 39 Issue 6 Page 401  - August 2003
      doi:10.1046/j.1440-1754.2003.00178.x


      Review ArticleSoy infant formula and phytoestrogens
      PG Tuohy
      Abstract:  Soy infant formula contains high levels of the isoflavones,
genistein and daidzein, which are commonly referred to as phytoestrogens.
These are non-steroidal chemicals with structural similarities to estrogen.
Infants consuming soy formula have high levels of circulating isoflavones.
These are an order of magnitude greater than the levels of isoflavones which
have been shown to produce physiological effects in adult women consuming a
high soy diet. There is conflicting evidence about the risks and benefits of
soy phytoestrogens, with research presenting a contradictory picture. Some
reviewers suggest that early exposure to soy may prevent cancer and heart
disease. However, there is very little research on the effects of
consumption of soy phytoestrogens by human neonates. Against this generally
positive view there is an increasing number of recent reports that suggest
that in experimental animals, phytoestrogens have adverse effects with
respect to carcinogenesis, reproductive function, immune function, and
thyroid disease. Despite the absence of adequate scientific research that
quantifies the level of risk to infants, most would argue for a
precautionary approach to be taken in situations where there are potential
developmental effects from the consumption of pharmacologically active
compounds in infancy and childhood.



Esther Grunis, IBCLC
Lis Maternity Hospital
Tel Aviv, Israel



             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2